1. AHRO : Austin Health Research Online

Christopher Christophi

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Christopher Christophi
Full Name
Christophi, Christopher
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Refined By:
Author:  Malcontenti-Wilson, Caterina
Author:  Muralidharan, Vijayaragavan
Author:  Chan, Lie Sam

Results 1-4 of 4 (Search time: 0.006 seconds).

Publication YearTitleAuthor(s)
118-Aug-2013Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor.Fifis, Theodora; Nguyen, Linh; Malcontenti-Wilson, Caterina; Chan, Lie Sam; Nunes Costa, Patricia Luiza; Daruwalla, Jurstine; Nikfarjam, Mehrdad ; Muralidharan, Vijayaragavan ; Waltham, Mark; Thompson, Erik W; Christophi, Christopher 
215-Nov-2012Spatial morphological and molecular differences within solid tumors may contribute to the failure of vascular disruptive agent treatments.Nguyen, Linh; Fifis, Theodora; Malcontenti-Wilson, Caterina; Chan, Lie Sam; Costa, Patricia Nunes Luiza; Nikfarjam, Mehrdad ; Muralidharan, Vijayaragavan ; Christophi, Christopher 
31-Jan-2008Alterations in vascular architecture and permeability following OXi4503 treatment.Chan, Lie Sam; Malcontenti-Wilson, Caterina; Muralidharan, Vijayaragavan ; Christophi, Christopher 
48-Jul-2007Effect of vascular targeting agent Oxi4503 on tumor cell kinetics in a mouse model of colorectal liver metastasis.Chan, Lie Sam; Malcontenti-Wilson, Caterina; Muralidharan, Vijayaragavan ; Christophi, Christopher